Thyroid Diseases (Part II) Notes

Hyperthyroidism (Thyrotoxicosis)

  • Definition: state of too much thyroid hormone with elevated T3 and T4.

  • Types:

    • Primary hyperthyroidism: issue is with the thyroid gland itself (the target gland).

    • Secondary hyperthyroidism: issue is with the pituitary gland causing excess TSH secretion.

    • Other etiologies: extremely high exogenous thyroid hormone ingestion can cause a hyperthyroid picture.

  • Primary hyperthyroidism

    • Causes: thyroid tumor, autoimmune disease (Graves' disease).

    • Graves' disease: autoimmune stimulation of the thyroid by autoantibodies that activate TSH receptors.

    • Lab pattern: ↑ T3 and ↑ T4; ↓ TSH due to negative feedback; TRAB (thyrotropin receptor antibody) commonly present and can test for Graves' disease.

    • Graves' disease is the most common cause of thyrotoxicosis; women are ~5× more likely than men to develop Graves' disease.

    • Pathophysiology: autoantibody against the thyroid stimulates TSH receptors, promoting T3/T4 production.

    • Clinical signs/symptoms: goiter (enlarged neck), ophthalmopathy (exophthalmos, double vision, corneal disease), dermopathy (orange-peel texture of skin, especially on lower extremities).

    • If untreated or treated causally, the thyroid hormone remains high; negative feedback lowers TSH further (often undetectable).

  • Secondary hyperthyroidism

    • Cause: pituitary gland overproduction of TSH (e.g., pituitary tumor).

    • Lab pattern: ↑ T3 and ↑ T4 with ↑ or inappropriately normal/↑ TSH; TRH from hypothalamus may be suppressed due to high TSH signaling.

    • In the lab, TRH testing could show ↓ TRH (hypothalamus response) though in practice this test is rarely needed.

  • Treatments for Graves'/thyrotoxicosis (not curative, but controls signs):

    • Beta blockers: control symptoms like tachycardia by reducing heart rate effects of thyroid hormone.

    • Methimazole: inhibits thyroid hormone biosynthesis and secretion.

    • Radioactive iodine: destroys thyroid tissue; risks hypothyroidism thereafter requiring replacement therapy.

    • Surgery: thyroidectomy; preferred when thyroid cancer is suspected; can help avoid eye problems associated with radioactive iodine.

  • Signs focusing on Graves' disease and thyrotoxicosis

    • Goiter: enlarged neck due to enlarged thyroid.

    • Ophthalmopathy: exophthalmos or other corneal involvement; diplopia.

    • Dermopathy: orange-peel skin texture (pretibial myxedema) on legs.

  • Conceptual note on feedback and lab interpretation

    • Negative feedback in primary hyperthyroidism:

    • ↑ T3/T4 → ↓ TSH caused by pituitary suppression.

    • Expression: extIf[T3,T4]exthigh<br>ightarrowextTSHlowext{If } [T3,T4] ext{ high} <br>ightarrow ext{TSH low}

    • In secondary hyperthyroidism, pituitary overproduction of TSH raises T3/T4 despite feedback.

    • Expression: extTSHext↑<br>ightarrow[T3,T4]ext↑ext{TSH} ext{ ↑} <br>ightarrow [T3,T4] ext{ ↑}

Secondary Hyperthyroidism (pituitary-driven)

  • Definition: hyperthyroid state due to pituitary gland abnormality causing excess TSH secretion.

  • Lab pattern: ↑ TSH with ↑ T3 and ↑ T4 (positive feedback on T3/T4, though physiologically the hypothalamus will respond by reducing TRH).

  • Diagnostic nuance: TRH testing could show suppression of hypothalamic input; discussion focuses on distinguishing pituitary from hypothalamic causes.

Hypothyroidism

  • Overview: underproduction of thyroid hormones.

  • Types:

    • Primary hypothyroidism: problem lies in the thyroid gland itself.

    • Secondary hypothyroidism: problem lies in the pituitary gland (↓ TSH).

    • Tertiary hypothyroidism: problem lies in the hypothalamus (↓ TRH).

  • Primary hypothyroidism

    • Common autoimmune cause: Hashimoto's thyroiditis.

    • Autoantibodies: anti-TPO (thyroid peroxidase) and anti-thyroglobulin antibodies.

    • Lab pattern: ↓ T3 and ↓ T4; ↑ TSH due to loss of negative feedback.

    • Epidemiology: autoimmune disease more common in developed countries; more prevalent in middle-aged women.

    • Symptoms suggestsive of hypothyroidism: weight gain, fatigue, cold intolerance, hair loss, slowed heart rate, depression.

    • Goiter is common.

    • Treatment: hormone replacement with synthetic T4 (levothyroxine); T4 can be converted to T3 in vivo.

  • Secondary hypothyroidism

    • Cause: pituitary gland failure leading to ↓ TSH.

    • Lab pattern: ↓ T3 and ↓ T4 with ↓ TSH; hypothalamus may respond with ↑ TRH.

    • Possible causes: infection, stroke, tumors, or panhypopituitarism (deficiency of multiple pituitary hormones).

  • Tertiary hypothyroidism

    • Cause: hypothalamic deficiency of TRH leading to ↓ TSH and ↓ T3/T4.

  • Congenital hypothyroidism

    • Affected babies may have insufficient thyroid hormone production from birth.

    • Newborn screening is essential (screening around 24 hours after birth).

    • Early detection is crucial to prevent irreversible brain damage and mental retardation.

    • Treatment: lifelong thyroid hormone replacement therapy.

Laboratory testing of thyroid function (overview of tests and interpretation)

  • Primary approach: start with TSH measurement using sensitive assays (STSH or ultrasensitive TSH, UTSH).

    • If TSH is abnormal, proceed to assess thyroid hormones (free T4, total T4, free T3, total T3).

    • TSH monitoring is also used to follow thyroid hormone replacement therapy.

  • Thyroid hormones and what to measure

    • Free T4 (biologically active form): often the most informative single test after abnormal TSH; indicates current thyroid status.

    • Total T4: measures both free and bound T4; used when binding proteins are normal;

    • Total T4 can be affected by binding proteins (see below).

    • Free T3: biologically active; not as commonly measured; useful when suspecting T3 thyrotoxicosis; limited clinical use.

    • Total T3: affected by thyroid-binding globulin; may be used when suspecting isolated T3 abnormalities.

  • Binding proteins and their clinical impact

    • Thyroxine-binding globulin (TBG) and other binding proteins affect total hormone levels.

    • Increased binding proteins raise total T4; decreased binding proteins lower total T4.

    • Factors increasing binding proteins: estrogen therapy, pregnancy.

    • Factors decreasing binding proteins: drugs, renal disease, liver disease, malnutrition.

  • T3 uptake and Free Thyroxine Index (FTI)

    • T3 uptake: measure of how well T3 binds to proteins; used to calculate FTI when binding proteins are abnormal.

    • FTI (Free Thyroxine Index) is an estimated index of thyroid status when binding proteins are abnormal, often calculated as:

    • extFTIext(approx)=racextTotalT4imesextT3uptake100ext{FTI} ext{ (approx)} = rac{ ext{Total T4} imes ext{T3 uptake}}{100}

    • Interpretation of FTI:

    • Increased FTI suggests hyperthyroidism; decreased FTI suggests hypothyroidism; used when binding abnormalities confound direct measurements (e.g., during pregnancy).

  • Antibody testing in thyroid disease

    • Thyroid peroxidase antibody (anti-TPO) / thyroid microsomal antibody (TMAB): autoantibody against thyroperoxidase; common in Hashimoto's; may be present in Graves' (less specific for Graves).

    • Thyroglobulin antibodies: bind thyroglobulin; can inhibit thyroid hormone synthesis; more common in Hashimoto's.

    • Antithyrotropin receptor antibody (TRAB) or TSH receptor antibodies (TSI): stimulates TSH receptor; typical in Graves' disease; promotes increased T3/T4 production.

  • Special antibody notes

    • TRAB/TSI positivity supports Graves' disease diagnosis in the appropriate clinical context.

    • TMAB and anti-TPO are more associated with Hashimoto's but must be interpreted with other lab results and signs.

  • TRH stimulation test (historical, less commonly used now)

    • Purpose: differentiate hypothalamic (tertiary) from pituitary (secondary) causes of hypothyroidism when unclear.

    • Procedure: measure baseline TSH, inject TRH, measure TSH at 15, 30, and 60 minutes post-injection.

    • Expected patterns:

    • Primary hypothyroidism: TSH remains elevated at 30 minutes (and later).

    • Normal individual: typical rise and fall pattern (squares in gray in the provided slide).

    • Hypothalamic (tertiary) hypothyroidism: gradual rise pattern (triangle) indicating inadequate TRH supply.

    • Pituitary (secondary) hypothyroidism: blunted or absent TSH response to TRH (line with Xs).

    • Note: TRH stimulation is rarely necessary with modern, sensitive TSH assays, but remains a teaching tool for differentiating hypothalamic vs pituitary origins.

Signs and symptoms: quick reference (opposites)

  • Hyperthyroidism vs hypothyroidism symptoms (illustrative contrasts):

    • Tachycardia vs bradycardia

    • Weight loss vs weight gain

    • Heat intolerance vs cold intolerance

    • Tremor, anxiety, sweating vs fatigue, lethargy

    • Goiter can be present in both hyper- and hypothyroidism

Quick clinical correlations and review points

  • Graves' disease is the prototypical primary hyperthyroidism and the most common cause of thyrotoxicosis.

  • The hallmark lab pattern for Graves'/primary hyperthyroidism: high T3/T4, low or undetectable TSH, TRAB positive.

  • Secondary hyperthyroidism presents with high TSH and high T3/T4; hypothalamic feedback reduces TRH, but pituitary overproduction dominates.

  • Primary hypothyroidism shows high TSH with low T3/T4; autoimmune Hashimoto's is a leading cause; anti-TPO and anti-thyroglobulin antibodies common.

  • Secondary hypothyroidism shows low TSH with low T3/T4; panhypopituitarism is a potential cause; TRH may be elevated as compensation.

  • Tertiary hypothyroidism involves the hypothalamus (low TRH), leading to low TSH and low T3/T4.

  • Congenital hypothyroidism detected via newborn screening is critical to prevent irreversible neurodevelopmental damage; treatment is lifelong hormone replacement.

  • Laboratory testing pathway typically starts with TSH (sensitive assay), followed by measurements of free/total T4 and free/total T3 to define primary vs secondary causes.

  • The relationship between TBG and total thyroid hormone levels explains why total T4/T3 can be misleading in pregnancy, estrogen therapy, or other states altering binding proteins; FTI can help interpret status when binding proteins are abnormal.

  • Antibody testing (anti-TPO, anti-thyroglobulin, TRAB) helps differentiate Hashimoto's from Graves' and supports the clinical picture.

  • The TRH stimulation test is a historical tool but can still aid in distinguishing hypothalamic vs pituitary origins when modern assays are inconclusive.

  • Practical implications: management of Graves' includes symptom control (beta blockers), reduction of hormone synthesis (methimazole), potential thyroid ablation (radioactive iodine), and sometimes surgery; hypothyroidism management centers on lifelong thyroid hormone replacement with levothyroxine.

  • Real-world relevance: thyroid hormones are essential for neurological development in infants and for metabolic regulation throughout life; misdiagnosis or delayed treatment can lead to significant morbidity.

Summary contrasts (quick reference)

  • Primary hyperthyroidism: ↑ T3/T4, ↓ TSH; Graves' disease is common; TRAB positive.

  • Secondary hyperthyroidism: ↑ T3/T4, ↑ or inappropriately normal/low TSH; pituitary origin; TRH may be suppressed.

  • Primary hypothyroidism: ↓ T3/T4, ↑ TSH; Hashimoto's common; anti-TPO/anti-thyroglobulin positive.

  • Secondary hypothyroidism: ↓ T3/T4, ↓ TSH; pituitary origin; possible panhypopituitarism.

  • Tertiary hypothyroidism: ↓ TRH, ↓ TSH, ↓ T3/T4.

  • Congenital hypothyroidism: newborn screening essential; treat with lifelong hormone replacement.